REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.

Vernon SD, Rond C, Bell J, Butler B, Isolampi S, Otteson A, Phalwane P, Mower S, Roundy S, Kaufman DL, Cash AB, Bateman L

Open source

DOI: 10.3389/fnins.2025.1627462
Published: 2025
Container: Frontiers in neuroscience
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fnins.2025.1627462,
  title = {REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.},
  author = {Vernon SD and Rond C and Bell J and Butler B and Isolampi S and Otteson A and Phalwane P and Mower S and Roundy S and Kaufman DL and Cash AB and Bateman L},
  year = {2025},
  journal = {Frontiers in neuroscience},
  doi = {10.3389/fnins.2025.1627462},
  url = {https://doi.org/10.3389/fnins.2025.1627462}
}

RIS

TY  - JOUR
TI  - REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.
AU  - Vernon SD
AU  - Rond C
AU  - Bell J
AU  - Butler B
AU  - Isolampi S
AU  - Otteson A
AU  - Phalwane P
AU  - Mower S
AU  - Roundy S
AU  - Kaufman DL
AU  - Cash AB
AU  - Bateman L
PY  - 2025
JO  - Frontiers in neuroscience
DO  - 10.3389/fnins.2025.1627462
UR  - https://doi.org/10.3389/fnins.2025.1627462
ER  -

APA

SD, V., C, R., J, B., B, B., S, I., A, O., P, P., S, M., S, R., DL, K., AB, C., & L, B. (2025). REGAIN: a randomized controlled clinical trial of oxaloacetate for improving the symptoms of long COVID.. Frontiers in neuroscience. https://doi.org/10.3389/fnins.2025.1627462

Source records

pubmed · retrieved 2026-09-25T17:30:05.081Z